Sagimet Biosciences Ownership | Who Owns Sagimet Biosciences?

Sagimet Biosciences Ownership Summary

Sagimet Biosciences is owned by 7.91% institutional investors, 8.41% insiders, and 83.69% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 2.96% of SGMT shares.

SGMT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sagimet Biosciences	7.91%	8.41%	83.69%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Baker bros. advisors lp	953.00K	2.96%	$3.11M
Hhlr advisors	724.80K	2.25%	$2.36M
Pfm health sciences, lp	649.01K	2.02%	$2.12M
Millennium management	160.91K	0.50%	$524.57K
Ikarian capital	11.98K	0.04%	$39.07K
Schonfeld strategic advisors	-	-	-
Squarepoint ops	-	-	-
Virtu financial	-	-	-
Citigroup	-	-	-
Nea management company	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pfm health sciences, lp	649.01K	0.15%	$2.12M
Hhlr advisors	724.80K	0.07%	$2.36M
Baker bros. advisors lp	953.00K	0.03%	$3.11M
Ikarian capital	11.98K	0.00%	$39.07K
Millennium management	160.91K	0.00%	$524.57K
Schonfeld strategic advisors	-	-	-
Squarepoint ops	-	-	-
Virtu financial	-	-	-
Citigroup	-	-	-
Nea management company	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Baker bros. advisors lp	953.00K	0.03%	-
Pfm health sciences, lp	649.01K	0.15%	-
Hhlr advisors	724.80K	0.07%	-
Ikarian capital	11.98K	0.00%	-
Srs capital advisors	-	-	-115.00

Top Sellers

Holder	Shares	% Assets	Change
Nea management company	-	-	-2.00M
Millennium management	160.91K	0.00%	-532.34K
683 capital management	-	-	-138.26K
Citigroup	-	-	-111.21K
Squarepoint ops	-	-	-50.48K

Sold Out

Holder	Change
Srs capital advisors	-115.00
Simplex trading	-17.15K
Man group	-17.32K
Shay capital	-19.33K
Virtu financial	-25.04K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	6	-91.43%	2,545,717	-85.38%	7	0.26%	1	-96.77%	1	-94.74%
Dec 31, 2024	71	5.97%	17,500,774	-10.97%	55	1.49%	32	39.13%	19	-17.39%
Sep 30, 2024	67	-20.24%	19,656,790	-6.06%	61	1.42%	23	-46.51%	23	4.55%
Jun 30, 2024	84	3.70%	20,925,652	-7.45%	65	1.08%	43	-34.85%	22	100.00%
Mar 31, 2024	81	58.82%	22,609,187	56.52%	77	0.41%	66	144.44%	11	10.00%

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 23, 2024	Kemble George	Executive Chairman	Sell	$74.83K
Jul 19, 2024	Martins Eduardo Bruno	Chief Medical Officer	Sell	$25.91K
Jul 19, 2024	Rozek Elizabeth	General Counsel and CCO	Sell	$33.83K
Jul 19, 2024	Kemble George	Executive Chairman	Sell	$43.60K
Mar 26, 2024	Happel David	President & CEO	Buy	$63.73K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	-	4
2024 Q2	-	-
2024 Q1	1	-

SGMT Ownership FAQ

Who Owns Sagimet Biosciences?

Sagimet Biosciences shareholders are primarily institutional investors at 7.91%, followed by 8.41% insiders and 83.68% retail investors. The average institutional ownership in Sagimet Biosciences's industry, Biotech Stocks , is 63.96%, which Sagimet Biosciences falls below.

Who owns the most shares of Sagimet Biosciences?

Sagimet Biosciences’s largest shareholders are Baker bros. advisors lp (953K shares, 2.96%), Hhlr advisors (724.8K shares, 2.25%), and Pfm health sciences, lp (649.01K shares, 2.02%). Together, they hold 7.23% of Sagimet Biosciences’s total shares outstanding.

Does Blackrock own Sagimet Biosciences?

BlackRock is not among the top 10 institutional shareholders of Sagimet Biosciences.

Who is Sagimet Biosciences’s biggest shareholder by percentage of total assets invested?

Pfm health sciences, lp is Sagimet Biosciences’s biggest shareholder by percentage of total assets invested, with 0.15% of its assets in 649.01K Sagimet Biosciences shares, valued at 2.12M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools